openPR Logo
Press release

Meningococcal Vaccines Market

03-08-2022 01:52 PM CET | Health & Medicine

Press release from: Persistence Market Research

/ PR Agency: Persistence Market Research
Meningococcal Vaccines Market 2022

Meningococcal Vaccines Market 2022

Meningococcal Vaccines Market 2022

The Meningococcal Vaccines Market is expected to grow on an unabashed note in the next decade. With a worldwide shortage of healthcare staff, the healthcare IT solutions comprising web-based staffing platforms are doing the rounds. The future scenario won't be any different. These platforms would show the gaps, i.e. actual dearth of healthcare personnel like nurse's doctors, technicians, lab workers, and clinicians, which would help the entire healthcare vertical to take measures to bridge the gap between demand and supply. This would be an important development in the healthcare industry going forward.

The meningococcal vaccine market has expanded to a significant extent over the past few years in correspondence to the parent market. Constant research and development in meningococcal vaccines for various meningococcal disease preventive applications, coupled with the sanctions of subsidy & support of government organizations for immunization program are among the significant factors that are anticipated to drive the growth of the meningococcal vaccine market during the forecast period.

Planning Forward? Access Sample Of Meningococcal Vaccines Market Report!

Expansion of the age group indication related to new sero-groups is boosting the potential population pool, thus boosting the market growth. As per the latest research by PMR, the global meningococcal vaccine market is estimated to account for ~ US$ 6.5 billion in terms of revenue by the end of 2029. The meningococcal vaccine market report also projects a significant growth prospective with a projected average Y-o-Y growth rate of ~ 10% during the forecast period.

Company Profiles:

Sanofi Pasteur Inc.
Wyeth Pharmaceuticals

How About Revitalizing The Strategy-Oriented Funnel To Stay Ahead In The Meningococcal Vaccines Market?

PR Image Meningococcal Vaccines Market

Although many effective meningococcal vaccines have already been developed, persistent product gaps still remain. Creating stable meningococcal vaccine supply in developing countries provides significant growth opportunities for the manufacturers of meningococcal vaccines. To ensure stable supply, manufacturers must look for committed financing, high-quality manufacturing capacity, strong regulatory systems, and predictable demand. This also provides opportunities for local or regional players to partner with global players and stimulate procurement, as well as penetrate markets with high unmet needs.

Collaborations between multiple firms to evaluate and develop meningococcal vaccines and new supply and healthcare funding models are becoming progressively necessary to respond resourcefully to emergency outbreaks of infectious diseases such as meningococcal disease. Even after powerful competition in high-value vaccines markets, collaborations with emerging and developing countries is becoming complex, and the involvement of multiple manufacturers as well as private- and public-sector investments are essential for developing new resistive meningococcal vaccines against emerging infectious diseases.

Planning To Introduce An Offbeat Product/Technology In The Meningococcal Vaccines Market? Go To "Purchase Now" To Have Our Meningococcal Vaccines Market Report!

Balanced Supply to Developed and Developing Regional Markets to Ensure Sustained Immunization

There is evidence that augmented demand for Gavi-aided meningococcal vaccines is encouraging the entry of a larger number of suppliers into the vaccine market. This is encouraging competition among players following the entry of new technologies into the market. Gavi's support is based on a country's ability to pay, as it intends to put countries on a trajectory toward financial sustainability. The co-financing commitments of a country increases its national income until it reaches a threshold. At the end of this process, countries are fully self-financing vaccines.

Every year, some countries are entering into an accelerated transition phase. For instance, 16 countries, which include Vietnam, Cuba, Angola, Indonesia, Bhutan, Honduras, Mongolia, Sri Lanka, etc., entered into a transition phase and reached the end of the full self-financing stage. This is expected to ensure equal immunization coverage across the globe and create growth opportunities in emerging meningococcal vaccine markets. The manufacturers of meningococcal vaccines are gradually focusing on value-driven services to boost their market penetration.

The addition of meningococcal vaccines to national immunization programs is expected to ensure the sustainable and affordable supply of these vaccines in the public as well as private sectors. This is estimated to accelerate the demand for meningococcal vaccines among the pediatric age group, thus contributing to meningococcal vaccine market growth. In addition, the expansion of the indication of certain meningococcal vaccines for use in certain age groups can be partially attributed to the growing consumption of meningococcal vaccine units across the globe.

For instance, in February 2018, the Ministry of Health, Government of Australia announced the upgradations of NIP to add Nimenrix-quadrivalent ACWY vaccines to the national immunization program of Australia. In July 2018, the Ministry of Health France declared that immunization with MenC vaccines is obligatory for all young children effective from 2018. Moreover, in 2014, single-dose meningococcal vaccine was added to the national immunization program of Pakistan.

PMR has segmented the global market for meningococcal vaccine based on product type, age group, distribution channel, and region. By product type, the market for meningococcal vaccine is further segmented into Serogroup B Meningococcal Vaccine (MenB-FHpb/MenB-4C), Meningococcal Conjugate Vaccine (MCV4) and Meningococcal Polysaccharide Vaccine (MPSV4). On the basis of age group, the meningococcal vaccine market is further segmented into Infants (0-24 months), Children, Adolescents and Young Adults, and Adults.

On the basis of distribution channel, the meningococcal vaccine market is segmented into Retail Sales and Institutional Sales. The institutional sales segment is further classified into Community Clinics, Public Health Agencies and Hospitals. By region, the meningococcal vaccine market is segment into Europe, Latin America, North America, South Asia, East Asia, Oceania, and the Middle East & Africa. The report tracks some of the major companies operating in the meningococcal vaccine market, which include GlaxoSmithKline Biologicals SA, Sanofi Pasteur SA, Wyeth Pharmaceuticals Inc. (a subsidiary of Pfizer Inc.), and Serum Institute of India Ltd.

Media Contact:

Persistence Market Research
305 Broadway,7th Floor New York City, NY 10007 United States
Call +1-646-568-7751
Call +1 800-961-0353

About PersistenceMarketResearch:

PersistenceMarketResearch is an esteemed company with a reputation of serving clients across domains of information technology (IT), healthcare, and chemicals. Our analysts undertake painstaking primary and secondary research to provide a seamless report with a 360 degree perspective. Data is compared against reputed organizations, trustworthy databases, and international surveys for producing impeccable reports backed with graphical and statistical information.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Meningococcal Vaccines Market here

News-ID: 2572899 • Views:

More Releases from Persistence Market Research

Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Frozen Foods Market Heats Up with Innovation and Growing Consumer Demand
Market Overview: The frozen foods market consists of a wide range of products, including frozen fruits and vegetables, meat and seafood, ready-to-eat meals, and desserts. These products are preserved through freezing to maintain freshness and quality for an extended period. Market Size and Growth: The global market for frozen foods is forecasted to be of valuation US$ 281.0 Billion in the year 2022 which is expanding at a value CAGR of 5.1% and
The Global Graphene Market's Striking Growth and Innovative Applications
The Global Graphene Market's Striking Growth and Innovative Applications
Introduction Graphene, a single layer of carbon atoms arranged in a hexagonal lattice, has gained global recognition for its extraordinary properties, such as exceptional electrical and thermal conductivity, mechanical strength, and flexibility. Since its isolation in 2004 by Andre Geim and Konstantin Novoselov, graphene has sparked considerable interest in both scientific and industrial communities. This report explores the current state of the graphene market and its potential growth opportunities. Get Access To
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analysis, Emerging Trends with Upcoming Developments
Business Opportunities in Cyber Security Mesh Market : Top Countries Data Analys …
Market Overview: The projected global market size for cyber security mesh is expected to reach $8.8 billion by the year 2033, with an estimated valuation of $1.2 billion by 2023. This market is poised to experience a compound annual growth rate (CAGR) of 21.7% from 2023 to 2033. The global Cyber Security Mesh market is poised for significant growth as organizations worldwide grapple with the escalating threat landscape. Cybersecurity has become an
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation and Industry Size
Synthetic Beta-Carotene Market To Boost Incredible Growth: 2033, Share Valuation …
Key market trends included a shift towards natural and plant-based ingredients, as consumers sought cleaner labels and healthier options. This drove the demand for naturally sourced beta-carotene, but synthetic beta-carotene still had its place due to its cost-effectiveness and consistency in production. The market was also influenced by regulatory changes and evolving dietary preferences, which affected the application and formulation of synthetic beta-carotene in various products. To obtain the latest market

All 5 Releases

More Releases for Meningococcal

Meningococcal Vaccines Market Report Up to 2031
Visiongain has published a new report on Meningococcal Vaccines Market Report 2021-2031: Forecasts by Vaccine Type (Conjugate, Polysaccharide, Others), by End-user (Paediatric, Adult, Traveler), by Brand (Bexsero, Menactra, Menveo, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios. Download Exclusive Sample of Report @ Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations
Global Meningococcal Vaccines Market Research Report
This report studies the global Meningococcal Vaccines market status and forecast, categorizes the global Meningococcal Vaccines market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report GlaxoSmithKline JN-International Medical Novartis International Sanofi Pfizer Baxter International Geographically, this report studies the top producers and
Meningococcal Vaccines Market Growth by 2028 | GlaxoSmithKline, Polysaccharide M …
Partnerships between the private sector and public institutions have been the chief agenda of global public health initiatives. The last few years have witnessed an increase in several private-public partnerships specifically focussing on vaccine provision in developing countries. Partnerships like the International Coordinating Group on Vaccine Provision for Epidemic Meningitis Control (ICG) help magnify the vaccine outreach to remote areas of the world with the maximum need. The governments of
Meningococcal Vaccines Market | Rising Incidence of Meningococcal Disease Propel …
The global Meningococcal Vaccines Market consists of a good number of established players who are on a quest to expand their market shares. The competition in the market has been stiffening over the past decade, partly due to the innovative business strategies of leading players, and majorly on account of the continual entry of new players. The companies operating in the pharmaceutical industry can easily expand their horizons by manufacturing
Meningococcal Vaccines Market: Regional & Competitive Analysis
A new Transparency Market Research report states that the global meningococcal vaccines market stood at US$1.5 bn in 2013 and is predicted to reach US$4.4 bn in 2022. It is expected to expand at a CAGR of 12.40% from 2014 to 2022. The title of the report is “Meningococcal Vaccines Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2022”. View Full Report: As per the
Meningococcal Vaccines Market to Reach US$4.4 bn by 2022, Concerns over Increasi …
Global Meningococcal Vaccines Market: Snapshot Meningococcal disease is caused by Neisseria meningitides, a gram-negative bacterium, and the majority of infections are caused by six serogroups out of many. The disease is mainly prevalent in infants, adolescents, and people suffering with risk of asplenia. The growing morbidity and mortality of meningococcal disease among vast populations has made it a global concern. Read the Comprehensive Overview of Meningococcal Vaccines Market: The incidence of invasive